On June 7, the U.S. Food and Drug Administration (FDA) approved the drug aducanumab for the treatment of Alzheimer’s disease. Read a breakdown on what this means for people living with Alzheimer’s disease and family caregivers.
Wisconsin Alzheimer’s Institute (WAI) is excited to welcome Sarah Klein in her new role as WAI administrator.
The 7th annual Breaking The Silence event welcomed more than 200 attendees on April 15, meeting for the first time virtually.
The program was the sixth edition of the Addressing Systemic Racism education series, held Friday, November 20.
WAI Regional Milwaukee Office director’s accomplishments are featured in new issue of Quarterly magazine
Dr. Carlsson joined the Dementia Matters podcast for an interview November 5, 2020
In a discussion that covered the long legacy of discrimination against Black people in American science and its continued effects on people of color’s health and quality of life, the fifth Addressing Systemic Racism webinar drew an audience of more than 250.
Documentary featuring WRAP participants and researchers will premiere in November.
The event explored the untold story of how American descendants of slavery experience worse health outcomes than other groups, an important foundation of existing health disparities in the United States. Watch a recording
In recognition of Juneteenth Day, on June 19, 2020 the WAI Regional Milwaukee Office hosted a webinar “Addressing Systemic Racism: From its Origins to its Impact Throughout Life.”